The possible beneficial effect of favoring adipocyte differentiation in the treatment of obesity was in part already suggested by the positive outcome on insulin resistance of PPARγ agonists, which act, among others, by promoting adipogenesis. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.